Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02750241
Other study ID # 16-0040
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 2016
Est. completion date January 2019

Study information

Verified date December 2019
Source The University of Texas Medical Branch, Galveston
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Breast cancer survivors, from diagnosis until the end of life, go through many transitions. One major transition is the significant decrease of physical activity immediately after diagnosis. Despite the known benefits of physical activity—speeding recovery time and reduced cancer recurrence risk—only 1 in 3 survivors met physical activity recommendations of 150 minutes of moderate-intensity activity per week. Physical activity interventions have shown effectiveness in helping breast cancer survivors increase physical activity during treatment, but limited evidence-based physical activity interventions have been incorporated into the clinic and community. To address this limitation, the investigators are partnering with the UTMB breast cancer support group to conduct a 12-week physical activity intervention, Pink Warrior.

The goal of this study is to compare an intervention that uses active games versus an intervention uses pedometer to encourage physical activity such as walking within breast cancer survivors in active cancer treatment. The study will include breast cancer survivor between the ages of 18 - 70 whom currently gets less than 150 minutes of planned physical activity per week and received a breast cancer diagnosis within 0 to 6 months. Participants will be randomized to participate in the support group using the active video game-based physical activity intervention (Wii and Xbox active games) or to participate in the existing UTMB breast cancer support group with pedometers (Digi-Walker CW-700/701). The investigators hypothesize that by engaging in active video gaming, breast cancer survivors will be motivated to initiate and maintain physical activity during treatment. This will ultimately increase functional capacity and prevent functional disability in breast cancer survivors.


Description:

Increasing and maintaining physical activity among female breast cancer (BC) survivors during treatment remains an unresolved problem in BC survivorship care. BC survivors, from diagnosis until the end of life, go through many transitions. One major transition is the significant decline of physical activity immediately after diagnosis. Despite the known benefits of physical activity—speeding recovery time and reduced cancer recurrence risk—less than 30% of survivors met physical activity recommendations. Physical activity interventions have shown effectiveness in helping BC survivors increase activity during treatment, but limited evidence-based activity interventions have been disseminated into the clinic and community. To address this limitation, we are partnering with the UTMB breast cancer support group to conduct a 12-week physical activity intervention, Pink Warrior, which will investigate the feasibility of implementing active video game-based physical activity intervention among BC survivors undergoing treatment within the support group setting. Participants (N = 60) will be randomized to participate in the support group using the active video game-based physical activity intervention or to participate in the existing UTMB breast cancer support group with pedometers. Our specific aims are:

Aim 1: Evaluate the feasibility and acceptability of active video game-based physical activity intervention among BC survivors undergoing treatment within the support group setting. Measures of feasibility will include weekly attendance records, number of completed home-based worksheets, number of participants completing the program activities, technological issues, and adverse events.

Aim 2: Compare the support group using the active video game-based physical activity intervention to the existing UTMB breast cancer support group with pedometer. Primary outcomes will be changes in physical activity. Secondary outcomes will be changes in physical function, dietary pattern, and quality of life.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date January 2019
Est. primary completion date January 2019
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

1. Provide informed consent

2. Diagnosed with primary female breast cancer within 0 to 6 months period of time

3. English-speaking between the ages of 18 and 70

4. Able to read and write in English

5. Obtained approval from oncologists for the participant to be involved in the physical activity based support group

6. Able to travel to the UTMB Breast Health Center

7. Able to move arms and legs as well as ambulate

8. Able to see TV screen from a distance of 2 to 4 feet

Exclusion Criteria:

1. Being pregnant

2. Dementia

3. Currently engage in =150 minutes of planned moderate physical activity per week for the prior week

4. Are involved in another physical activity intervention

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Active video game-based intervention
Attend 12 weekly group session at the UTMB Breast Health Clinic to play the active video games using Wii Fit U or Xbox 360. Participate in self-paced home sessions Monitor daily, weekly, and monthly steps using Wii Fit Meter Feedback on physical activity and physical function
Pedometer
Attend 3 monthly UTMB Breast Cancer Support Group Sessions Monitor daily, weekly, and monthly steps using a pedometer (Digi-walker CW-700/701) Feedback on physical activity and physical function

Locations

Country Name City State
United States The University of Texas Medical Branch Galveston Texas

Sponsors (1)

Lead Sponsor Collaborator
The University of Texas Medical Branch, Galveston

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Change in weight Change in body weight between 14 weeks and baseline as measured by a weight scale in the clinic Change in weight from baseline to 14 weeks
Other Change in waist circumference Change in waist circumference between 14 weeks and baseline as measured by Seca-203 Change in waist circumference from baseline to 14 weeks
Other Change in physical activity minutes, measured by the Community Healthy Activities Model Program for Seniors Self-reported physical activity questionnaire Change in physical activity minutes from baseline to 14 weeks
Other Change in physical function, measured by PROMIS measure specific to cancer survivors Changes in overall self-reported physical functions between 14 weeks and baseline as measured by PROMIS-Ca Bank v1.1-Physical Function Change in physical function from baseline to 14 weeks
Other Change in fatigue, measured by PROMIS measure specific to cancer survivors Changes in overall self-reported fatigue level between 14 weeks and baseline as measured by PROMIS-Ca Bank v1.1-Fatigue Change in fatigue from baseline to 14 weeks
Other Change in exercise motivation, measured by autonomous motivation specific to physical activity Behavioral regulation in Exercise Questionnaire-2 will be used Change in motivation from baseline to 14 weeks
Other Change in psychological feelings, measured by Psychological Need Satisfaction in Exercise Scale Sub-scales included perceived competence, perceived autonomy, and perceived relatedness Change in psychological feelings from baseline to 14 weeks
Other Change in self-regulation, measured by Rovinak et al. scale Sub-scales include exercise goals and exercise plans Change in self-regulation from baseline to 14 weeks
Other Feasibility-Adherence Adherence will be measured by number of participants who completed at least 80% of the program activities. 14 weeks
Other Feasibility-Attrition Attrition will be measured by percentage of people who dropped out of the intervention program. 14 weeks
Other Feasibility-Technological Issues Technological issues will be measured by counting number of occurrence 14 weeks
Other Feasibility-Adverse Events Adverse events will be measured by counting number of occurrence 14 weeks
Other Acceptability Participant acceptability and satisfaction will be assessed by a questionnaire with 5-point scale responses 14 weeks
Primary Change in physical activity steps per day as measured by an Actigraph monitor Change in steps per day between 14 weeks and baseline as measured by an Actigraph monitor Change in steps per day from baseline to 14 weeks
Primary Change in physical activity minutes as measured by an Actigraph monitor Change in physical activity minutes between 14 weeks and baseline as measured by an Actigraph monitor Change in physical activity minutes from baseline to 14 weeks
Secondary Change in physical function as measured by the Short Physical Performance Battery (SPPB) The SPPB consists of six components: repeated chair sit and stands, balance test, semi-tandem stand, tandem stand, side-by-side stand, and eight feet walk Change in physical function from baseline and 14 weeks
Secondary Change in dietary pattern as measured by the Dietary Screener Questionnaire Change in dietary pattern from baseline and 14 weeks] [Safety Issue: No] The Dietary Screener Questionnaire used in the National Health and Nutrition Examination Survey 2009-10. The screener captures frequency of fruits, vegetables, dairy/calcium, added sugar, whole grains/fiber, red meat, and processed meat consumption within the past 30 days Change in dietary pattern from baseline and 14 weeks
Secondary Change in quality of life as measured by the Functional Assessment of Cancer Therapy-Breast measure Changes in physical, social, emotional, functional, and additional well-being between 14 weeks and baseline as measured by FACT-B Change in quality of life from baseline and 14 weeks
Secondary Change in hand grip strength as measured by hand dynamometer Hand dynamometer estimates the muscle strength generated from flexor muscles of the hand and the forearm Change in hand grip strength from baseline to 14 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A